PYRUVATE KINASE DEFICIENCY ANAEMIA

This adverse event was reported 9 times

PYRUVATE KINASE DEFICIENCY ANAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MITAPIVAT 1 0.0008
1 DEFERASIROX 2 0.0001
2 LEVETIRACETAM ORAL 3 0.0000
3 LEVETIRACETAM INJECTION 3 0.0000
4 LEVETIRACETAM 3 0.0000
5 MYCOPHENOLATE MOFETIL 3 0.0000
6 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 3 0.0000
7 TACROLIMUS OINTMENT 0.1% 1 0.0000
8 TACROLIMUS EXTENDED-RELEASE CAPSULES 1 0.0000
9 TACROLIMUS 1 0.0000
See all drugs enriched for association with PYRUVATE KINASE DEFICIENCY ANAEMIA

These drug classes are most commonly taken by patients reporting PYRUVATE KINASE DEFICIENCY ANAEMIA:

# Drug class Count
0 Iron Chelator [EPC] 2
1 Alkylating Drug [EPC] 1
2 Corticosteroid [EPC] 1
3 Pyruvate Kinase Activator [EPC] 1
4 Vitamin B12 [EPC] 1
5 Vitamin C [EPC] 1
6 Vitamin D [EPC] 1
See all common drug classes associated with PYRUVATE KINASE DEFICIENCY ANAEMIA

PYRUVATE KINASE DEFICIENCY ANAEMIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Pyruvate Kinase Activator [EPC] 1 0.0008
1 Iron Chelator [EPC] 2 0.0001
2 Alkylating Drug [EPC] 1 0.0000
3 Vitamin D [EPC] 1 0.0000
4 Vitamin B12 [EPC] 1 0.0000
5 Vitamin C [EPC] 1 0.0000
6 Corticosteroid [EPC] 1 0.0000
See all drug classes enriched for association with PYRUVATE KINASE DEFICIENCY ANAEMIA